Agilent Technologies - A Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $141.29
Forecasted Upside: 2.58%
Number of Analysts: 17
Breakdown:
1 Sell Ratings
5 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$137.74 As of 04/26/2024 05:26 PM ET

▲ +1.37 (1.00%)

1 month | 3 months | 12 months

Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

^$141.29

▲ +2.58% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $141.29, with a high forecast of $165.00 and a low forecast of $90.00. The average price target represents a 2.58% upside from the last price of $137.74.

Current Consensus is Moderate Buy

The current consensus among 17 contributing investment analysts is to moderate buy stock in Agilent Technologies. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

11/3/2022

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

2/1/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

5/2/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

7/31/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

10/29/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

1/27/2024

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

3/27/2024

0 strong buy ratings
11 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

4/26/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/10/2024	Barclays	Boost Target	Underweight ➝ Underweight	$125.00 ➝ $135.00	Low
4/5/2024	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$145.00 ➝ $163.00	Low
4/4/2024	Evercore ISI	Boost Target	In-Line ➝ In-Line	$132.00 ➝ $145.00	Low
3/26/2024	Oppenheimer	Boost Target	Outperform ➝ Outperform	$67.00 ➝ $90.00	Low
2/28/2024	UBS Group	Boost Target	Neutral ➝ Neutral	$130.00 ➝ $155.00	Low
2/28/2024	Citigroup	Boost Target	Neutral ➝ Neutral	$130.00 ➝ $145.00	Low
2/28/2024	Evercore ISI	Lower Target	In-Line ➝ In-Line	$135.00 ➝ $132.00	Low
2/28/2024	Barclays	Boost Target	Underweight ➝ Underweight	$120.00 ➝ $125.00	Low
1/25/2024	Barclays	Boost Target	Underweight ➝ Underweight	$100.00 ➝ $120.00	Low
12/20/2023	JPMorgan Chase & Co.	Boost Target	Overweight ➝ Overweight	$140.00 ➝ $165.00	Low
12/13/2023	Wolfe Research	Initiated Coverage	Outperform	$140.00	Low
12/12/2023	Bank of America	Downgrade	Buy ➝ Neutral	$130.00 ➝ $133.00	Low
12/7/2023	The Goldman Sachs Group	Boost Target	Buy ➝ Buy	$128.00 ➝ $145.00	Low
11/22/2023	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$160.00 ➝ $145.00	Low
11/21/2023	Robert W. Baird	Lower Target	Outperform ➝ Outperform	$140.00 ➝ $130.00	Low
11/17/2023	UBS Group	Downgrade	Buy ➝ Neutral	$163.00 ➝ $125.00	Low
9/29/2023	Barclays	Lower Target	Underweight ➝ Underweight	$110.00 ➝ $105.00	Low
9/28/2023	Sanford C. Bernstein	Initiated Coverage	Market Perform	$123.00	Low
8/16/2023	TD Cowen	Boost Target	Outperform ➝ Outperform	$145.00 ➝ $147.00	Low
8/16/2023	Evercore ISI	Lower Target	In-Line ➝ In-Line	$124.00 ➝ $120.00	Low
8/16/2023	Jefferies Financial Group	Lower Target	Buy ➝ Buy	$150.00 ➝ $146.00	Low
8/16/2023	JPMorgan Chase & Co.	Lower Target	Overweight ➝ Overweight	$155.00 ➝ $150.00	Low
8/16/2023	Robert W. Baird	Lower Target	Outperform ➝ Outperform	$144.00 ➝ $140.00	Low
8/16/2023	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$160.00 ➝ $150.00	Low
8/16/2023	Barclays	Lower Target	Underweight ➝ Underweight	$115.00 ➝ $110.00	Low
7/31/2023	Barclays	Downgrade	Equal Weight ➝ Underweight	$116.00	Low
6/27/2023	Barclays	Lower Target		$135.00 ➝ $130.00	Low
5/24/2023	888	Reiterated Rating	Maintains		Low
5/24/2023	58.com	Reiterated Rating	Maintains		Low
5/24/2023	TD Cowen	Lower Target	Outperform	$168.00 ➝ $145.00	Low
5/24/2023	SVB Securities	Lower Target	Outperform	$170.00 ➝ $145.00	Low
5/24/2023	Evercore ISI	Lower Target	Outperform	$150.00 ➝ $126.00	Low
5/24/2023	Bank of America	Lower Target	Buy	$164.00 ➝ $144.00	Low
5/24/2023	Stifel Nicolaus	Lower Target	Hold	$153.00 ➝ $135.00	Low
5/24/2023	Robert W. Baird	Lower Target	Outperform	$174.00 ➝ $144.00	Low
5/24/2023	Credit Suisse Group	Lower Target	Outperform	$170.00 ➝ $160.00	Low
5/24/2023	Wells Fargo & Company	Lower Target	Overweight	$170.00 ➝ $160.00	Low
5/24/2023	Citigroup	Lower Target	Neutral	$150.00 ➝ $130.00	Low
5/24/2023	Barclays	Lower Target	Equal Weight	$140.00 ➝ $135.00	Low
5/11/2023	Barclays	Initiated Coverage	Equal Weight	$140.00	Low
3/1/2023	Credit Suisse Group	Boost Target	Outperform	$165.00 ➝ $170.00	Low
3/1/2023	Robert W. Baird	Boost Target	Outperform	$170.00 ➝ $174.00	Low
1/10/2023	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$150.00 ➝ $170.00	Low
1/6/2023	SVB Leerink	Boost Target	Outperform	$160.00 ➝ $170.00	Low
12/20/2022	UBS Group	Boost Target	Buy	$152.00 ➝ $170.00	Low
11/22/2022	Cowen	Boost Target		$160.00 ➝ $168.00	Low
11/22/2022	Jefferies Financial Group	Boost Target		$158.00 ➝ $168.00	Low
11/22/2022	Evercore ISI	Boost Target		$140.00 ➝ $155.00	Low
11/22/2022	Cowen	Boost Target		$160.00 ➝ $168.00	Low
11/22/2022	Wells Fargo & Company	Boost Target		$135.00 ➝ $150.00	Low
11/22/2022	Robert W. Baird	Boost Target		$160.00 ➝ $170.00	Low
11/22/2022	Citigroup	Boost Target	Neutral	$145.00 ➝ $150.00	Low
11/22/2022	SVB Leerink	Boost Target	Outperform	$145.00 ➝ $160.00	Low
11/22/2022	KeyCorp	Boost Target	Overweight	$155.00 ➝ $165.00	Low
8/24/2022	Credit Suisse Group	Initiated Coverage	Outperform	$165.00	Low
8/22/2022	Evercore ISI	Boost Target		$145.00	Low
8/22/2022	Cowen	Boost Target		$160.00	Low
8/17/2022	Bank of America	Boost Target	Buy	$148.00 ➝ $155.00	Low
8/17/2022	Wells Fargo & Company	Boost Target	Equal Weight	$130.00 ➝ $135.00	Low
8/17/2022	Citigroup	Boost Target	Neutral	$140.00 ➝ $145.00	Low
8/17/2022	Robert W. Baird	Boost Target	Outperform	$155.00 ➝ $160.00	Low
7/20/2022	UBS Group	Initiated Coverage	Buy	$139.00	Low
7/14/2022	The Goldman Sachs Group	Lower Target	Buy	$170.00 ➝ $140.00	Low
7/8/2022	Citigroup	Downgrade	Buy ➝ Neutral	$175.00 ➝ $140.00	N/A
6/2/2022	KeyCorp	Lower Target	Overweight	$195.00 ➝ $155.00	High
5/26/2022	The Goldman Sachs Group	Reiterated Rating	Buy	$170.00	Low
5/25/2022	Robert W. Baird	Boost Target	Outperform	$155.00 ➝ $161.00	High
4/25/2022	Wells Fargo & Company	Lower Target	Overweight ➝ Equal Weight	$160.00 ➝ $130.00	Medium
4/19/2022	Truist Financial	Downgrade	Buy ➝ Hold		Medium
2/23/2022	Evercore ISI	Lower Target	Outperform	$170.00 ➝ $155.00	High
2/23/2022	Bank of America	Lower Target	Buy	$179.00 ➝ $160.00	High
2/23/2022	Cowen	Lower Target	Outperform	$187.00 ➝ $178.00	High
2/23/2022	Stifel Nicolaus	Lower Target	Hold	$169.00 ➝ $145.00	High
2/23/2022	Wells Fargo & Company	Lower Target	Overweight	$180.00 ➝ $160.00	High
2/23/2022	Robert W. Baird	Lower Target		$170.00 ➝ $161.00	High
2/23/2022	Citigroup	Lower Target	Buy	$190.00 ➝ $175.00	High
2/23/2022	SVB Leerink	Lower Target	Outperform	$175.00 ➝ $145.00	High
11/23/2021	Cowen	Boost Target	Hold ➝ Outperform	$180.00 ➝ $187.00	High
11/23/2021	Stifel Nicolaus	Boost Target	Hold	$162.00 ➝ $169.00	High
11/23/2021	Bank of America	Boost Target	Buy	$177.00 ➝ $179.00	High
11/23/2021	SVB Leerink	Boost Target	Outperform	$170.00 ➝ $175.00	Low
10/14/2021	Cowen	Lower Target	Outperform	$200.00 ➝ $180.00	Low
9/17/2021	Cowen	Boost Target	Outperform	$165.00 ➝ $200.00	Low
8/18/2021	Cowen	Boost Target	Outperform	$150.00 ➝ $165.00	Medium
8/18/2021	Jefferies Financial Group	Boost Target	Buy	$155.00 ➝ $185.00	Medium
8/18/2021	Wells Fargo & Company	Boost Target	Overweight	$150.00 ➝ $180.00	Medium
8/18/2021	SVB Leerink	Boost Target	Outperform	$160.00 ➝ $170.00	Medium
8/18/2021	KeyCorp	Boost Target	Positive ➝ Overweight	$160.00 ➝ $195.00	Medium
8/18/2021	Stifel Nicolaus	Boost Target	Hold	$136.00 ➝ $162.00	Low
8/18/2021	Robert W. Baird	Boost Target	Outperform	$144.00 ➝ $170.00	Low
8/18/2021	Citigroup	Boost Target	Buy	$160.00 ➝ $190.00	Low
7/12/2021	KeyCorp	Boost Target	Overweight	$157.00 ➝ $160.00	Low
6/22/2021	Societe Generale	Upgrade	Hold ➝ Buy		Low
5/26/2021	KeyCorp	Boost Target	Overweight	$148.00 ➝ $157.00	High
5/26/2021	SVB Leerink	Boost Target	Outperform	$140.00 ➝ $145.00	High
5/26/2021	Wells Fargo & Company	Boost Target	Overweight	$140.00 ➝ $150.00	High
5/26/2021	Robert W. Baird	Boost Target	Outperform	$137.00 ➝ $144.00	High
5/26/2021	Citigroup	Boost Target	Buy	$150.00 ➝ $160.00	High
3/19/2021	Redburn Partners	Upgrade	Neutral ➝ Buy		Low
3/18/2021	Citigroup	Upgrade	Neutral ➝ Buy	$150.00	Medium
2/17/2021	KeyCorp	Boost Target		$130.00 ➝ $148.00	Low
2/17/2021	Citigroup	Boost Target		$120.00 ➝ $135.00	Low
2/17/2021	Robert W. Baird	Boost Target	Outperform	$133.00 ➝ $137.00	Low
2/17/2021	Wells Fargo & Company	Boost Target	Overweight	$120.00 ➝ $140.00	Low
2/17/2021	Cowen	Boost Target	Outperform	$125.00 ➝ $135.00	Low
2/17/2021	SVB Leerink	Boost Target	Outperform	$130.00 ➝ $140.00	Low
2/17/2021	Bank of America	Upgrade	Neutral ➝ Buy	$147.00	Low
1/12/2021	Mizuho	Initiated Coverage	Buy	$51.00	Medium
12/23/2020	MKM Partners	Initiated Coverage	Buy	$57.00	N/A
12/15/2020	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$49.00	Low
12/10/2020	SVB Leerink	Boost Target	Outperform	$120.00 ➝ $130.00	High
12/3/2020	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform		Low
12/2/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$130.00	Low
11/25/2020	UBS Group	Upgrade	Neutral ➝ Buy	$103.00 ➝ $132.00	Low
11/24/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$110.00 ➝ $125.00	High
11/24/2020	Wells Fargo & Company	Boost Target	Overweight	$105.00 ➝ $120.00	High
11/24/2020	Robert W. Baird	Boost Target	Outperform	$104.00 ➝ $118.00	High
11/24/2020	SVB Leerink	Boost Target	Outperform	$100.00 ➝ $120.00	High
11/9/2020	KeyCorp	Initiated Coverage	Overweight	$130.00	High
11/9/2020	HSBC	Upgrade	Hold ➝ Buy	$30.70	High
11/3/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight		Low
9/30/2020	Atlantic Securities	Initiated Coverage	Neutral	$105.00	Low
8/25/2020	Stifel Nicolaus	Lower Target	Hold	$39.00 ➝ $37.00	Low
8/19/2020	Bank of America	Boost Target	Neutral	$99.00 ➝ $103.00	Low
8/19/2020	Stifel Nicolaus	Boost Target	Hold	$85.00 ➝ $100.00	Medium
8/19/2020	Jefferies Financial Group	Boost Target	Buy	$95.00 ➝ $110.00	Medium
8/19/2020	SVB Leerink	Boost Target	Outperform	$95.00 ➝ $100.00	High
8/19/2020	Robert W. Baird	Boost Target	Outperform	$87.00 ➝ $104.00	High
8/19/2020	Needham & Company LLC	Reiterated Rating	Hold		High
8/19/2020	Citigroup	Boost Target	Neutral	$85.00 ➝ $100.00	High
8/19/2020	Wells Fargo & Company	Reiterated Rating	Overweight	$100.00 ➝ $105.00	High
7/27/2020	Credit Suisse Group	Boost Target	Neutral	$53.00 ➝ $54.00	Medium
7/20/2020	Bank of America	Boost Target	Neutral	$88.00 ➝ $99.00	High
7/13/2020	The Goldman Sachs Group	Initiated Coverage	Neutral		High
7/1/2020	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Neutral		Medium
5/22/2020	Cfra	Lower Target	Hold	$89.00 ➝ $85.00	Low
5/22/2020	Bank of America	Boost Target	Neutral	$74.00 ➝ $88.00	Low
5/22/2020	UBS Group	Boost Target	Neutral	$84.00 ➝ $87.00	Medium
5/22/2020	Cowen	Boost Target	Outperform	$80.00 ➝ $95.00	Medium
5/22/2020	Wells Fargo & Company	Boost Target	Overweight	$82.00 ➝ $95.00	Low
5/22/2020	SVB Leerink	Boost Target	Outperform	$90.00 ➝ $95.00	Low
4/28/2020	Royal Bank of Canada	Initiated Coverage	Sector Perform		Low
4/28/2020	UBS Group	Lower Target	Neutral	$90.00 ➝ $84.00	Low
4/16/2020	SunTrust Banks	Lower Target	Hold	$90.00 ➝ $75.00	Low
4/2/2020	Stifel Nicolaus	Lower Target	Hold	$85.00 ➝ $73.00	Medium
3/30/2020	Wells Fargo & Company	Lower Target	Overweight	$100.00 ➝ $82.00	Low
3/26/2020	Barclays	Lower Target	Equal Weight	$85.00 ➝ $76.00	Low
3/20/2020	Citigroup	Lower Target	Neutral	$85.00 ➝ $75.00	Medium
2/24/2020	Needham & Company LLC	Downgrade	Buy ➝ Hold	$85.00	High
2/21/2020	Cfra	Lower Target	Hold	$60.00 ➝ $57.00	Low
2/19/2020	Piper Sandler	Boost Target	Overweight	$86.00 ➝ $96.00	Medium
2/19/2020	UBS Group	Boost Target	Buy ➝ Neutral	$87.00 ➝ $90.00	High
2/12/2020	HSBC	Upgrade	Hold ➝ Buy		Low
1/28/2020	UBS Group	Reiterated Rating	Buy		Low
1/7/2020	Wells Fargo & Company	Initiated Coverage	Overweight	$100.00 ➝ $100.00	Medium
1/6/2020	Citigroup	Initiated Coverage	Neutral	$85.00	Low
1/3/2020	Needham & Company LLC	Initiated Coverage	Buy	$77.00	Medium
11/26/2019	UBS Group	Boost Target	Neutral	$82.00 ➝ $87.00	Low
11/26/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$85.00 ➝ $90.00	High
11/26/2019	Needham & Company LLC	Reiterated Rating	Buy	$92.00 ➝ $85.00	High
11/14/2019	Stifel Nicolaus	Initiated Coverage	Hold	$85.00	High
10/18/2019	UBS Group	Downgrade	Buy ➝ Neutral	$82.00	Medium
10/9/2019	Barclays	Lower Target	Equal Weight	$78.00 ➝ $76.00	Low
8/19/2019	Needham & Company LLC	Boost Target	Buy	$92.00	Low
8/15/2019	Robert W. Baird	Reiterated Rating	Outperform	$79.00 ➝ $82.00	High
8/15/2019	Piper Sandler Companies	Boost Target	Overweight	$83.00 ➝ $86.00	High
7/16/2019	Bank of America	Downgrade	Buy ➝ Neutral	$76.00	Low
7/15/2019	Barclays	Downgrade	Overweight ➝ Equal Weight	$86.00 ➝ $78.00	Low
6/11/2019	Piper Sandler Companies	Initiated Coverage	Overweight ➝ Overweight	$83.00	Low
5/30/2019	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform		Low
5/15/2019	Bank of America	Lower Target	Buy	$88.00 ➝ $82.00	High
5/15/2019	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$90.00 ➝ $85.00	High
5/15/2019	Barclays	Lower Target	Overweight	$88.00 ➝ $86.00	High

(Data available from 4/26/2019 forward)

News Sentiment Rating

1.08 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

20 very positive mentions
20 positive mentions
2 negative mentions
5 very negative mentions

Mentions as of

9/29/2023

16 very positive mentions
11 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

10/29/2023

14 very positive mentions
39 positive mentions
5 negative mentions
1 very negative mentions

Mentions as of

11/28/2023

32 very positive mentions
20 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

12/28/2023

32 very positive mentions
6 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

1/27/2024

31 very positive mentions
20 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

2/26/2024

32 very positive mentions
24 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/27/2024

32 very positive mentions
18 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

4/26/2024

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Today's Range

Now: $137.74

$135.00

$138.36

50 Day Range

MA: $141.53

$131.49

$149.36

52 Week Range

Now: $137.74

$96.80

$151.58

Volume

754,945 shs

Average Volume

1,562,308 shs

Market Capitalization

$40.36 billion

P/E Ratio

32.80

Dividend Yield

0.69%

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?: The following equities research analysts have issued stock ratings on Agilent Technologies in the last year: 58.com Inc., 888 Holdings plc, Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Oppenheimer Holdings Inc., Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, SVB Securities, TD Cowen, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for A.
What is the current price target for Agilent Technologies?: 17 Wall Street analysts have set twelve-month price targets for Agilent Technologies in the last year. Their average twelve-month price target is $141.29, suggesting a possible upside of 2.6%. JPMorgan Chase & Co. has the highest price target set, predicting A will reach $165.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $90.00 for Agilent Technologies in the next year.
View the latest price targets for A.
What is the current consensus analyst rating for Agilent Technologies?: Agilent Technologies currently has 1 sell rating, 5 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for A.
What other companies compete with Agilent Technologies?: Other companies that are similar to Agilent Technologies include Mettler-Toledo International, Illumina, Waters, Avantor and Teradyne. Learn More about companies similar to Agilent Technologies.
How do I contact Agilent Technologies' investor relations team?: Agilent Technologies' physical mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company's listed phone number is (800) 227-9770 and its investor relations email address is [email protected]. The official website for Agilent Technologies is www.agilent.com. Learn More about contacing Agilent Technologies investor relations.

Agilent Technologies - A Stock Price Target and Predictions

Analyst Price Target for A

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

1.08 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?

What is the current price target for Agilent Technologies?

What is the current consensus analyst rating for Agilent Technologies?

What other companies compete with Agilent Technologies?

How do I contact Agilent Technologies' investor relations team?